Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of February 15, 2026

By / February 18, 2026

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

BRIVIACT (brivaracetam)

Ucb inc Patent: 6,911,461 Expiration: Feb 21, 2026

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Bargain Hunting After Drug Patent Expirations: A…
Secure the Future of Branded Generics
The Industrialization of Telehealth: A Strategic…
Maximizing GLP-1 Market Exclusivity: Leveraging…
How Pharmaceutical Packaging Companies can Win the…
Sell More After Patents Die
Master the Patent Cliff for Better Pharmacy Margins
Buy Low, Dispense High
The Defensive Architecture of Biopharmaceutical…
Pharma Doesn’t Buy on Features. They Buy on Fear of…
Beat the Patent Thicket
Own the Generic Entry Timeline: From Orange Book…
Post-LOE? Win the War in the “Inactive” Ingredients:…
How to Survive the GLP-1 Patent War: A Strategic…
Profit from the Patent Gap
How to keep your drug on the market for five extra years
Profit From Weak Drug Patents: Identifying Weak…
Win the Patent Cliff: How the 12-Year Biologic…
The Data-Driven Guide to Winning the 2026 Patent Cliff
Quantifying Patent Risk: How to Factor PTRS into…
Cut Costs, Not Quality: How excipient vendors can…
Win the Patent Cliff: How to Track Patent Expiry and…
Policy Solutions to End Patent Thickets: Examining…
Predict Pharma Price Moves Using Patent Data

Navigating Forfeiture: The 7 Ways Generic Companies Can Lose 180-Day Exclusivity

The Impact of Paragraph IV Filings on Mid-Cap Pharma Valuations: A Strategic Investor Guide

Related Posts

Drug Patent Expirations for the Week of January 4, 2026

Patent Expiration / By

Drug Patent Expirations for the Week of January 18, 2026

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

Slash drug discovery timelines with GPT-Rosalind
Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry
Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits
Read the Clock Right: Mapping Regulatory Exclusivities for True Generic Drug Entry Timing
Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked

Popular Posts

CHEMOCENTRYX, INC. v. ZYDUS PHARMACEUTICALS (USA) INC.
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
Patent Expiration Dates: The Calendar Every Pharmaceutical Investor Watches
Maximizing Pharmaceutical Patent Longevity: A Mechanistic and Strategic Guide to IP Term Extension and Lifecycle Fortification
Brazilian Pharmaceuticals 2026: The Innovation & Patent Cliff Frontier
China’s Irreplaceable Role in the Global Generic Drug API Supply Chain (2026 Report)
Drug Patent Expiration: The Complete Strategic Guide to Loss of Exclusivity, Lifecycle Management, and the $400 Billion Cliff
When Blockbusters Fall, Business Development Rises: Win the Patent Cliff
The $236 Billion Cliff: How Pharma Loses Its Blockbusters—and What Replaces Them
The IRA Price Reset: What It Actually Does to Pharma Pricing, and What Comes Next

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested

Last Updated on February 18, 2026 by